Copyright
©The Author(s) 2019.
World J Gastroenterol. Dec 28, 2019; 25(48): 6928-6938
Published online Dec 28, 2019. doi: 10.3748/wjg.v25.i48.6928
Published online Dec 28, 2019. doi: 10.3748/wjg.v25.i48.6928
Table 2 Health related quality of life domains before and after directly acting antivirals treatment
Pre DAAs (n = 39) | Post DAAs (n = 39) | P value | |
Physical functioning | 75 ± 27.3 | 81.9 ± 22.2 | 0.005 |
Role limitation physical | 68.6 ± 40.4 | 73.7 ± 36.3 | 0.35 |
Bodily pain | 63.5 ± 32.2 | 69.2 ± 27.1 | 0.19 |
General health | 53.1 ± 21.2 | 65.9 ± 17.5 | < 0.001 |
Vitality | 54.2 ± 20.4 | 67.2 ± 18,1 | < 0.001 |
Social functioning | 66.8 ± 25.4 | 75.1 ± 20.6 | 0.03 |
Role limitation emotional | 64.8 ± 39.7 | 79.4 ± 34.7 | 0.02 |
Mental health | 60.5 ± 22.2 | 71.2 ± 18.9 | 0.002 |
Physical component summary | 62.8 ± 22.7 | 71.6 ± 21.2 | 0.002 |
Mental component summary | 59.8 ± 21.9 | 71.8 ± 19.1 | < 0.001 |
- Citation: Nardelli S, Riggio O, Rosati D, Gioia S, Farcomeni A, Ridola L. Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms. World J Gastroenterol 2019; 25(48): 6928-6938
- URL: https://www.wjgnet.com/1007-9327/full/v25/i48/6928.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i48.6928